Gaucher disease-induced pluripotent stem cells display decreased erythroid potential and aberrant myelopoiesis

Judi A. Sgambato, Tea Soon Park, Diana Miller, Leelamma M. Panicker, Ellen Sidransky, Yu Lun, Ola Awad, Søren M. Bentzen, Elias Zambidis, Ricardo A. Feldman

Research output: Contribution to journalArticle

Abstract

Gaucher disease (GD) is the most common lysosomal storage disease resulting from mutations in the lysosomal enzyme glucocerebrosidase (GCase). The hematopoietic abnormalities in GD include the presence of characteristic Gaucher macrophages that infiltrate patient tissues and cytopenias. At present, it is not clear whether these cytopenias are secondary to the pathological activity of Gaucher cells or a direct effect of GCase deficiency on hematopoietic development. To address this question,we differentiated induced pluripotent stemcells (iPSCs) derived from patients with types 1, 2, and 3 GD to CD34+/CD45+/CD43+/CD143+ hematopoietic progenitor cells (HPCs) and examined their developmental potential. The formation of GD-HPCs was unaffected. However, these progenitors demonstrated a skewed lineage commitment, with increased myeloid differentiation and decreased erythroid differentiation and maturation. Interestingly, myeloid colony-formation assays revealed that GD-HPCs, but not control-HPCs, gave rise to adherent, macrophage-like cells, another indication of abnormal myelopoiesis. The extent of these hematologic abnormalities correlated with the severity of the GCasemutations. All the phenotypic abnormalities of GD-HPCs observed were reversed by incubation with recombinant GCase, indicating that these developmental defects were caused by the mutated GCase. Our results show that GCase deficiency directly impairs hematopoietic development. Additionally, our results suggest that aberrant myelopoiesis might contribute to the pathological properties of Gaucher macrophages, which are central to GD manifestations. The hematopoietic developmental defects we observed reflect hematologic abnormalities in patients with GD, demonstrating the utility of GDiPSCs for modeling this disease.

Original languageEnglish (US)
Pages (from-to)878-886
Number of pages9
JournalStem cells translational medicine
Volume4
Issue number8
DOIs
StatePublished - Jul 27 2015

    Fingerprint

Keywords

  • Erythropoiesis
  • Hematopoiesis
  • Hematopoietic stem cells
  • Induced pluripotent stem cells
  • Monocyte
  • Myeloid cells
  • Stem/progenitor cell

ASJC Scopus subject areas

  • Cell Biology
  • Developmental Biology

Cite this

Sgambato, J. A., Park, T. S., Miller, D., Panicker, L. M., Sidransky, E., Lun, Y., Awad, O., Bentzen, S. M., Zambidis, E., & Feldman, R. A. (2015). Gaucher disease-induced pluripotent stem cells display decreased erythroid potential and aberrant myelopoiesis. Stem cells translational medicine, 4(8), 878-886. https://doi.org/10.5966/sctm.2014-0213